DiffInt: A Pharmacophore-Aware Diffusion Model for Structure-Based Drug Design with Explicit Hydrogen Bond Interaction Guidance

30 July 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The design of drug molecules is a critical stage in the drug discovery process. The use of pharmacophore models in structure-based drug discovery has long played an important role in efficient development. Significant progress has been made in recent years in the generation of 3D molecules via deep generation models. However, while many existing models have succeeded in incorporating structural information of target proteins, they have not been able to address important interactions between proteins and drug molecules, especially hydrogen bonds, explicitly. In this study, we propose DiffInt as a novel structure-based approach that explicitly addresses interactions. The model naturally incorporates hydrogen bonds between the protein and ligand by treating them as pseudoparticles. The experimental results show that DiffInt reproduces hydrogen bonds and that the hydrogen binding energies significantly outperform those of existing models. To facilitate the use of our tool for generating new drug molecules based on any protein three-dimensional structure, we have made the source code and trained model available on GitHub (https://github.com/sekijima-lab/DiffInt) under the MIT license, with the execution environment provided on Google Colab.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.